Table 1 Cohort description
Patient Details | Total (n = 132) |
|---|---|
Age at diagnosis: mean years (SD ±) | 53.3 (SD ±13.6) |
Time to recurrence: mean months (SD ±) | 38.7 (SD ±27.7) |
Recurrence location | |
 Loco-regional | 58 (44%) |
 Distal | 74 (56%) |
Neoadjuvant Chemo Rx | |
 Received | 58 (44%) |
 Did not receive | 74 (56%) |
Surgery | |
 Mastectomy | 83 (62.8%) |
 Wide local excision | 49 (37.2%) |
Survival: Months | |
 Overall: mean (SD ±) | 60 (38.3) |
 Post-recurrence survival: mean (SD ±) | 20.7 (21.1) |
Original subtype | |
 Luminal A | 67 (50.7%) |
 Luminal B | 10 (7.5%) |
 HER2 | 15 (11.3%) |
 Triple negative | 40 (30.5%) |
Recurrence subtype | |
 Luminal A | 54 (40.9%) |
 Luminal B | 9 (6.9%) |
 HER2 | 16 (12.1%) |
 Triple negative | 53 (40.1%) |